Impaired Left Ventricular Ejection Fraction
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Impaired Left Ventricular Ejection Fraction trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Impaired Left Ventricular Ejection Fraction trials you may qualify forHeart failure with preserved ejection (HFpEF) disproportionately affects Veterans and is the number one reason for hospital discharge in the VA Health Care Syst…
Previous studies have shown that patients with heart failure with reduced pumping function and preserved kidney function experience improved symptoms, longer su…
Evidence for the usefulness of the defibrillator in cases of preserved left ventricular ejection fraction and well-tolerated ventricular tachycardia (without ca…
Although advances in treatment and patient management have considerably improved post-infarction prognosis, the risk of sudden cardiac death remains a major con…
The present study is designed to test the effect of AZD3427 on renal perfusion in participants with heart failure and reduced eGFR (30 to 90 mL/min/1.73m2).